...
首页> 外文期刊>Human psychopharmacology: clinical and experimental >Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
【24h】

Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.

机译:Schneiderian第一流的症状氟伏沙明治疗:一个案例报告。

获取原文
获取原文并翻译 | 示例

摘要

This communication describes a patient who developed Schneiderian first-rank symptoms in the course of treatment with fluvoxamine. The patient, a 28-year-old man suffering from panic disorder, developed several first-rank symptoms during fluvoxamine administration. These symptoms abated 1 week after fluvoxamine treatment was discontinued and haloperidol was started. Although haloperidol was discontinued, no further hallucinations or delusions occurred. This finding suggests that fluvoxamine can precipitate Schneiderian first-rank symptoms in some susceptible patients.
机译:这种通信描述了一个病人开发Schneiderian第一流的症状的氟伏沙明治疗。病人,一名28岁男子患有恐慌障碍,出现了一些优秀的症状氟伏沙明执政期间。减少氟伏沙明治疗后1周停止和氟哌啶醇就开始了。虽然氟哌啶醇是停止,没有进一步发生幻觉或妄想。发现表明,氟伏沙明可以沉淀在一些Schneiderian第一流的症状敏感的病人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号